Literature DB >> 35501409

Deficiency of the ywhaz gene, involved in neurodevelopmental disorders, alters brain activity and behaviour in zebrafish.

Ester Antón-Galindo1,2,3,4, Elisa Dalla Vecchia5, Javier G Orlandi6, Gustavo Castro7, Emilio J Gualda7, Andrew M J Young8, Marc Guasch-Piqueras1,3, Concepció Arenas1, Carlos Herrera-Úbeda1,3, Jordi Garcia-Fernàndez1,3, Fernando Aguado9,10, Pablo Loza-Alvarez7, Bru Cormand11,12,13,14, William H J Norton15, Noèlia Fernàndez-Castillo16,17,18,19.   

Abstract

Genetic variants in YWHAZ contribute to psychiatric disorders such as autism spectrum disorder and schizophrenia, and have been related to an impaired neurodevelopment in humans and mice. Here, we have used zebrafish to investigate the mechanisms by which YWHAZ contributes to neurodevelopmental disorders. We observed that ywhaz expression was pan-neuronal during developmental stages and restricted to Purkinje cells in the adult cerebellum, cells that are described to be reduced in number and size in autistic patients. We then performed whole-brain imaging in wild-type and ywhaz CRISPR/Cas9 knockout (KO) larvae and found altered neuronal activity and connectivity in the hindbrain. Adult ywhaz KO fish display decreased levels of monoamines in the hindbrain and freeze when exposed to novel stimuli, a phenotype that can be reversed with drugs that target monoamine neurotransmission. These findings suggest an important role for ywhaz in establishing neuronal connectivity during development and modulating both neurotransmission and behaviour in adults.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 35501409     DOI: 10.1038/s41380-022-01577-9

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  52 in total

1.  An association study between polymorphisms in three genes of 14-3-3 (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein) family and paranoid schizophrenia in northern Chinese population.

Authors:  Yanbin Jia; Xin Yu; Boyu Zhang; Yanbo Yuan; Qi Xu; Yucun Shen; Yan Shen
Journal:  Eur Psychiatry       Date:  2004-09       Impact factor: 5.361

2.  Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations.

Authors:  C Toma; B Torrico; A Hervás; R Valdés-Mas; A Tristán-Noguero; V Padillo; M Maristany; M Salgado; C Arenas; X S Puente; M Bayés; B Cormand
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

3.  Altered expression of 14-3-3 genes in the prefrontal cortex of subjects with schizophrenia.

Authors:  Frank A Middleton; Lansha Peng; David A Lewis; Pat Levitt; Karoly Mirnics
Journal:  Neuropsychopharmacology       Date:  2005-05       Impact factor: 7.853

4.  14-3-3ε and ζ regulate neurogenesis and differentiation of neuronal progenitor cells in the developing brain.

Authors:  Kazuhito Toyo-oka; Tomoka Wachi; Robert F Hunt; Scott C Baraban; Shinichiro Taya; Hayley Ramshaw; Kozo Kaibuchi; Quenten P Schwarz; Angel F Lopez; Anthony Wynshaw-Boris
Journal:  J Neurosci       Date:  2014-09-03       Impact factor: 6.167

5.  Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3ζ deficiency.

Authors:  P S Cheah; H S Ramshaw; P Q Thomas; K Toyo-Oka; X Xu; S Martin; P Coyle; M A Guthridge; F Stomski; M van den Buuse; A Wynshaw-Boris; A F Lopez; Q P Schwarz
Journal:  Mol Psychiatry       Date:  2011-11-29       Impact factor: 15.992

Review 6.  The neuroproteomics of schizophrenia.

Authors:  Jane A English; Kyla Pennington; Michael J Dunn; David R Cotter
Journal:  Biol Psychiatry       Date:  2011-01-15       Impact factor: 13.382

7.  14-3-3ζ deficient mice in the BALB/c background display behavioural and anatomical defects associated with neurodevelopmental disorders.

Authors:  Xiangjun Xu; Emily J Jaehne; Zarina Greenberg; Peter McCarthy; Eiman Saleh; Clare L Parish; Daria Camera; Julian Heng; Matilda Haas; Bernhard T Baune; Udani Ratnayake; Maarten van den Buuse; Angel F Lopez; Hayley S Ramshaw; Quenten Schwarz
Journal:  Sci Rep       Date:  2015-07-24       Impact factor: 4.379

8.  The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders.

Authors:  C Pagan; R Delorme; J Callebert; H Goubran-Botros; F Amsellem; X Drouot; C Boudebesse; K Le Dudal; N Ngo-Nguyen; H Laouamri; C Gillberg; M Leboyer; T Bourgeron; J-M Launay
Journal:  Transl Psychiatry       Date:  2014-11-11       Impact factor: 6.222

9.  Disruption of melatonin synthesis is associated with impaired 14-3-3 and miR-451 levels in patients with autism spectrum disorders.

Authors:  Cécile Pagan; Hany Goubran-Botros; Richard Delorme; Marion Benabou; Nathalie Lemière; Kerren Murray; Frédérique Amsellem; Jacques Callebert; Pauline Chaste; Stéphane Jamain; Fabien Fauchereau; Guillaume Huguet; Erik Maronde; Marion Leboyer; Jean-Marie Launay; Thomas Bourgeron
Journal:  Sci Rep       Date:  2017-05-18       Impact factor: 4.379

Review 10.  14-3-3 Proteins in Brain Development: Neurogenesis, Neuronal Migration and Neuromorphogenesis.

Authors:  Brett Cornell; Kazuhito Toyo-Oka
Journal:  Front Mol Neurosci       Date:  2017-10-12       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.